Changing Pathology Image by Image Minute by Minute
Larry Dentice, President & Director of MUSE Microscopy, Inc., recently unveiled our groundbreaking SmartPath MUSE Technology™ (SmartPath) System at LSI (Life Science Intelligence) USA ’24, the Emerging Medtech Summit. SmartPath harnesses the power of Microscopy with UV Surface Excitation (MUSE) technology. Click the button below to learn more about our innovative SmartPath Direct-to-Digital Pathology solution.
“Finally, a revolutionary technological breakthrough for fast-tracking a tissue diagnosis and cancer margins by an onsite or remote pathologist anywhere in the world, from a point-of-care biopsy, within minutes, and without tissue damaging chemicals or cryosections.”
– Dr. Jeffrey Edwards, DVM, MPH, MRVCS, DACVP
Sr. VP, Clinical Development, MUSE Microscopy, Inc.
In addition, for adoption of our SmartPath MUSE Technology™ (SmartPath), we are in the process of building a multi-tissue validation concordance study. Based on our initial findings, we are anticipating a high acceptance of this new technology.
Rapid. Slide-Free. Pathology.
Powered by MUSE Fluorescent Technology
Our Graphical User Interface (GUI) is designed with universally accepted icons making for an easier workflow that uses an integrated touch screen to operate and navigate. Watch our GUI video to see how easy it is to operate SmartPath.
Multiple Images in One Pass.
Within Minutes.
SmartPath Benefits
- SmartPath is a UV-based pathology imaging instrument that offers typically 10x the amount of information compared to today’s traditional images
- Easy-to-use tissue preparation with a simple workflow
- Conforms with global industry standards and security protocoltransmission of images/reports
- Results expected within minutes
- Software enables global digital readings for images and reports
- Easy access to QR or barcode enabled specimen cassettes
- Tissue integrity preserved for additional downstream analysis
- Water-based, non-toxic stains/dyes
Data Readiness for AI
AI is becoming widely accepted as a valid diagnostic tool in multiple medical clinical settings. AI-based technology companies can benefit from Smart Path’s data as a preferred platform for pathology diagnostic tools.
